Canadian Sec - Delayed Quote CAD

Ayurcann Holdings Corp. (AYUR.CN)

0.0250

0.0000

(0.00%)

At close: December 12 at 9:42:50 AM EST

AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE

Toronto, Ontario, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the three months ended September 30, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of consolidated financial st

GlobeNewswire 16 days ago

AYURF
AYURCANN TERMINATES BUSINESS COMBINATION

Toronto, Ontario, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announces that, further to its press releases dated June 27, 2024 (the “June 27 Release”) and November 20, 2024, it has sent a letter to Arogo Capital Acquisition Corporation (“Arogo”) terminating the Business Combination in accordance with Section 10.1(c) of the

GlobeNewswire 22 days ago

AYURF
AYURCANN PROVIDES UPDATE ON BUSINESS COMBINATION

Toronto, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announces that, further to its press release date June 27, 2024 (the “June 27 Release”), it has received correspondence from Arogo Capital Acquisition Corporation that the Business Combination has been terminated and a related demand for $250,000 in con

GlobeNewswire 23 days ago

AYURF
AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE

Toronto, Ontario, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, is pleased to announce its financial and operational results for the year ended June 30, 2024, the highlights of which are included in this news release. All figures are reported in Canadian dollars. The Company’s full set of consolidated audited financ

GlobeNewswire last month

AYURF
Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.

Ayurcann is an award-winning Canadian cannabis extraction company that specializes in the processing and manufacturing of cannabis 2.0 and 3.0 products: Ayurcann is the #1 producer of vapes in Ontario1, and Top 5 pre-roll manufacturer by volume in Ontario as of March 30, 20242. The revenue in the Canadian cannabis market is projected to reach US$5.63bn in 2024 and is expected to show an annual growth rate in the years 2024-2029 of 3.17%, resulting in a market volume of US$6.58bn by 20293.Upon co

GlobeNewswire 5 months ago

AYURF
AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE

Toronto, Ontario, May 27, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and nine months ended March 31, 2024, the highlights of which are included in this news release. All figures are repo

GlobeNewswire 6 months ago

AYURF
AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE

Toronto, Ontario, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and manufacturing of various derivative cannabis 2.0 and 3.0 products in the recreational market, is pleased to announce its financial and operational results for the three and six months ended December 31, 2023, the highlights of which are included in this news release. All fi

GlobeNewswire 9 months ago

AYURF
Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs

Pickering, Ontario, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is please to announce the following corporate updates. Corporate Update With the growth of the cannabis market and new pr

GlobeNewswire 11 months ago

AYURF
AYURCANN ANNOUNCES AGSM RESULTS

Toronto, Ontario, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company, specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to provide the following corporate updates. Annual General and Special Meeting The Company is pleased to announ

GlobeNewswire 11 months ago

AYURF

Performance Overview

Return	AYUR.CN	S&P/TSX Composite index
YTD	0.00%	+20.59%
1-Year	+25.00%	+24.91%
3-Year	-85.29%	+20.98%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Ayurcann Holdings Corp. (AYUR.CN)

AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE

AYURCANN TERMINATES BUSINESS COMBINATION

AYURCANN PROVIDES UPDATE ON BUSINESS COMBINATION

AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE

Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.

AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE

AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE

Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs

AYURCANN ANNOUNCES AGSM RESULTS

Performance Overview